Ultragenyx Pharmaceutical, Inc. (RARE)
14.30
-0.10
(-0.69%)
USD |
NASDAQ |
Sep 11, 16:00
14.30
0.00 (0.00%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Total Assets (Quarterly) : 1.264B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.264B |
| March 31, 2026 | 1.296B |
| December 31, 2025 | 1.532B |
| September 30, 2025 | 1.190B |
| June 30, 2025 | 1.306B |
| March 31, 2025 | 1.312B |
| December 31, 2024 | 1.503B |
| September 30, 2024 | 1.538B |
| June 30, 2024 | 1.618B |
| March 31, 2024 | 1.307B |
| December 31, 2023 | 1.497B |
| September 30, 2023 | 1.238B |
| June 30, 2023 | 1.311B |
| March 31, 2023 | 1.383B |
| December 31, 2022 | 1.552B |
| September 30, 2022 | 1.618B |
| June 30, 2022 | 1.321B |
| March 31, 2022 | 1.384B |
| December 31, 2021 | 1.531B |
| September 30, 2021 | 1.485B |
| June 30, 2021 | 1.512B |
| March 31, 2021 | 1.598B |
| December 31, 2020 | 1.793B |
| September 30, 2020 | 1.268B |
| June 30, 2020 | 1.314B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.233B |
| December 31, 2019 | 1.143B |
| September 30, 2019 | 879.94M |
| June 30, 2019 | 958.93M |
| March 31, 2019 | 1.008B |
| December 31, 2018 | 719.56M |
| September 30, 2018 | 765.14M |
| June 30, 2018 | 806.02M |
| March 31, 2018 | 817.35M |
| December 31, 2017 | 490.75M |
| September 30, 2017 | 435.05M |
| June 30, 2017 | 497.54M |
| March 31, 2017 | 545.82M |
| December 31, 2016 | 540.63M |
| September 30, 2016 | 515.17M |
| June 30, 2016 | 481.95M |
| March 31, 2016 | 524.18M |
| December 31, 2015 | 559.57M |
| September 30, 2015 | 602.13M |
| June 30, 2015 | 343.00M |
| March 31, 2015 | 355.84M |
| December 31, 2014 | 197.97M |
| September 30, 2014 | 210.93M |
| June 30, 2014 | 162.59M |
| March 31, 2014 | 172.71M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| AbbVie, Inc. | 135.12B |
| Biogen, Inc. | 32.09B |
| BioMarin Pharmaceutical, Inc. | 11.72B |
| Ionis Pharmaceuticals, Inc. | 2.995B |
| Regeneron Pharmaceuticals, Inc. | 41.73B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.548B |
| Shareholders Equity (Quarterly) | -291.00M |
| Debt to Equity Ratio | -4.131 |
| Current Ratio | 1.726 |
| Net Debt Paydown Yield | -1.90% |